VOICES Health Policy Research Center, Department of Orthopaedic Surgery, Stanford University.
Department of Orthopaedic Surgery, University of California San Francisco.
Spine J. 2023 Oct;23(10):1451-1460. doi: 10.1016/j.spinee.2023.06.391. Epub 2023 Jun 22.
Although spine procedures have historically been performed inpatient, there has been a recent shift to the outpatient setting for selected cases due to increased patient satisfaction and reduced cost. Effective postoperative pain management while limiting over-prescribing of opioids, which may lead to persistent opioid use, is critical to performing spine surgery in the outpatient setting.
To assess if there is an increased risk for new, persistent opioid use between inpatient and outpatient spine procedures.
Retrospective analysis using national administrative claims database.
A total of 390,049 opioid-naïve patients with a perioperative opioid prescription who underwent an inpatient or outpatient spine surgery.
Patients with perioperative opioid prescriptions who filled ≥ 1 opioid prescription between 90- and 180-days following surgery were defined as new, persistent opioid users.
We utilized a claims database to identify opioid-naïve patients who underwent lumbar or cervical fusion, total disc arthroplasty, or decompression procedures. We constructed a multivariable logistic regression to evaluate the association between inpatient versus outpatient surgery and the development of new, persistent opioid use while adjusting for several patient factors.
A total of 19,205 (11.7%) inpatient and 18,546 (8.2%) outpatient patients developed new, persistent opioid use. Outpatient lumbar and cervical spine surgery patients were significantly less likely to develop new, persistent opioid use following surgery compared to inpatient spine surgery patients (OR = 0.71 [95% confidence interval {CI}: 0.69, 0.73], p < .001). Average morphine milligram equivalents (MMEs) (inpatient = 1,476 MME +/- 22.7, outpatient = 1,072 MME +/- 18.5, p < .001) and average MMEs per day (inpatient = 91.6 MME +/- 0.32, outpatient = 77.7 MME +/- 0.28, p < .001) were lower in the outpatient cohort compared to the inpatient.
Our results support the shift from inpatient to outpatient spine procedures, as outpatient procedures were not associated with an increased risk for new, persistent opioid use. As more patients become candidates for outpatient spine surgery, predictors of new, persistent opioid use should be considered during risk stratification.
Level III Prognostic Study.
We utilized a national administrative claims database to identify opioid-naïve patients who underwent common spine procedures. Outpatient lumbar and cervical spine surgery patients were significantly less likely to be new, persistent opioid users following surgery compared to inpatient spine surgery patients. Our results support the shift to outpatient spine procedures.
尽管脊柱手术历来都是住院进行,但由于患者满意度提高和成本降低,最近已将部分病例转移到门诊进行。在门诊进行脊柱手术时,有效控制术后疼痛并限制阿片类药物的过度处方(这可能导致持续使用阿片类药物)至关重要。
评估住院和门诊脊柱手术之间是否存在新的、持续使用阿片类药物的风险增加。
利用国家行政索赔数据库进行的回顾性分析。
共 390049 名接受住院或门诊脊柱手术且术前无阿片类药物使用史、术后开具阿片类药物处方的患者。
术后 90-180 天内至少开具 1 次阿片类药物处方的患者被定义为新的、持续使用阿片类药物的患者。
我们利用索赔数据库确定接受腰椎或颈椎融合术、全椎间盘置换术或减压术的阿片类药物初治患者。我们构建了多变量逻辑回归模型,以评估住院与门诊手术与新的、持续使用阿片类药物之间的关联,同时调整了几个患者因素。
共有 19205 名(11.7%)住院患者和 18546 名(8.2%)门诊患者出现新的、持续使用阿片类药物。与住院脊柱手术患者相比,门诊腰椎和颈椎脊柱手术患者术后发生新的、持续使用阿片类药物的可能性显著降低(OR=0.71[95%置信区间:0.69, 0.73],p<.001)。门诊组的平均吗啡毫克当量(MME)(住院:1476 MME±22.7,门诊:1072 MME±18.5,p<.001)和平均每日 MME(住院:91.6 MME±0.32,门诊:77.7 MME±0.28,p<.001)均低于住院组。
我们的研究结果支持从住院转为门诊脊柱手术,因为门诊手术并未增加新的、持续使用阿片类药物的风险。随着越来越多的患者成为门诊脊柱手术的候选者,在风险分层时应考虑新的、持续使用阿片类药物的预测因素。
III 级预后研究。
我们利用国家行政索赔数据库确定了接受常见脊柱手术的阿片类药物初治患者。与住院脊柱手术患者相比,门诊腰椎和颈椎脊柱手术患者术后新的、持续使用阿片类药物的可能性显著降低。我们的研究结果支持向门诊脊柱手术的转变。